Literature DB >> 17987260

The value of tandem CSF/MRI evaluation for predicting disseminated disease in childhood central nervous system neoplasms.

Judy Pang1, Anuradha Banerjee, Tarik Tihan.   

Abstract

Leptomeningeal spread of childhood primary central nervous system (CNS) neoplasms, also known as leptomeningeal disease (LMD), significantly affects prognosis and treatment. Lumbar cerebrospinal fluid (CSF) cytology and spinal magnetic resonance imaging (MRI) are considered critical for diagnosis of LMD. It has been suggested that either CSF cytology or spinal MRI alone would miss LMD in up to 18% of children with CNS neoplasms. To determine the rate of LMD and the concordance of these two tests at our institution, we analyzed the results of concurrent CSF cytology and spinal MRI (tandem CSF/MRI) performed at the UCSF Pediatric Neuro-oncology Division. We identified all patients who underwent tandem CSF and MRI analysis during their treatment between 1990 and 2005. There were 127 tandem analyses from 78 patients, of which 115 were concordant. Among the remaining 12 discordant tandem analyses, spinal MRI was positive and CSF was negative for tumor in 8 patients, while CSF was positive and spinal MRI was normal in four others. In all discordant cases, positive spinal MRI was often associated with aggressive disease. Positive CSF cytology correlated with aggressive disease only in one patient who had evidence of disseminated intracranial tumor on MRI. In the absence of intracranial tumor spread or LMD on MRI, a positive CSF cytology did not correlate with aggressive disease or recurrence. Even though the number of cases is limited, our findings suggest that a positive CSF cytology with no other corroborating evidence of tumor spread or recurrence should be interpreted with caution.

Entities:  

Mesh:

Year:  2007        PMID: 17987260     DOI: 10.1007/s11060-007-9493-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis.

Authors:  C S Straathof; H G de Bruin; D W Dippel; C J Vecht
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

2.  CSF cytology has limited value in the evaluation of patients with ependymoma who have MRI evidence of metastasis.

Authors:  Igor M Poltinnikov; Thomas E Merchant
Journal:  Pediatr Blood Cancer       Date:  2006-08       Impact factor: 3.167

3.  Medulloblastoma.

Authors:  Catherine A. Mazzola; Ian F. Pollack
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

4.  Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.

Authors:  M Fouladi; A Gajjar; J M Boyett; A W Walter; S J Thompson; T E Merchant; J J Jenkins; J W Langston; A Liu; L E Kun; R L Heideman
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

5.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors:  P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

6.  Postoperative evaluation for disseminated medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes.

Authors:  S P Meyers; S L Wildenhain; J K Chang; E C Bourekas; P F Beattie; D N Korones; D Davis; I F Pollack; R A Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

7.  Prognostic implications for gadolinium enhancement of the meninges in low-grade astrocytomas of childhood.

Authors:  M D Hurwitz; P C Burger; P T Goldthwaite; T Tihan; M D Wharam; P G Fisher
Journal:  Pediatr Neurosurg       Date:  2001-02       Impact factor: 1.162

Review 8.  A review of leptomeningeal metastases in pediatrics.

Authors:  M C Chamberlain
Journal:  J Child Neurol       Date:  1995-05       Impact factor: 1.987

9.  Contrast-enhanced fluid-attenuated inversion recovery imaging for leptomeningeal disease in children.

Authors:  Paul D Griffiths; Stuart C Coley; Charles A J Romanowski; Tim Hodgson; Iain D Wilkinson
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

10.  Surveillance neuroimaging of intracranial medulloblastoma in children: how effective, how often, and for how long?

Authors:  Dawn E Saunders; Richard D Hayward; Kim P Phipps; Wui Khean Chong; Angela M Wade
Journal:  J Neurosurg       Date:  2003-08       Impact factor: 5.115

View more
  4 in total

1.  Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma.

Authors:  Jason Fangusaro; Clark Van Den Berghe; Tadanori Tomita; Veena Rajaram; Dolly Aguilera; Deli Wang; Stewart Goldman
Journal:  J Neurooncol       Date:  2010-11-01       Impact factor: 4.130

2.  Postoperative intraspinal subdural collections after pediatric posterior fossa tumor resection: incidence, imaging, and clinical features.

Authors:  J H Harreld; N Mohammed; G Goldsberry; X Li; Y Li; F Boop; Z Patay
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-22       Impact factor: 3.825

3.  Development of a standardized MRI scoring tool for CNS demyelination in children.

Authors:  L H Verhey; H M Branson; S Laughlin; M M Shroff; S M Benseler; B M Feldman; D L Streiner; J G Sled; B Banwell
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

4.  Clinical-MRI radiomics enables the prediction of preoperative cerebral spinal fluid dissemination in children with medulloblastoma.

Authors:  Hui Zheng; Jinning Li; Huanhuan Liu; Chenqing Wu; Ting Gui; Ming Liu; Yuzhen Zhang; Shaofeng Duan; Yuhua Li; Dengbin Wang
Journal:  World J Surg Oncol       Date:  2021-04-22       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.